Date & Time of Session - 1/12/26 - from 12:00 - 1:00 PM

Overview
Vasomotor symptoms occur in up to 80% of women during menopause. These symptoms can be debilitating and can have great implications on physical and mental well-being, with wider implications affecting relationships, workplace, and overall quality of life. Systemic hormone therapy, with estrogen alone or in combination with progestin, is the most effective therapy for vasomotor symptoms related to menopause.  Unfortunately, hormonal therapies are relatively contraindicated in survivors with hormonally mediated cancers, which includes most breast cancer survivors. Therefore, it is essential that our pharmacy team understands how to appropriately evaluate the risks and benefits of starting a patient on menopausal hormone therapy. It is also important that our pharmacy team is aware of the non-hormonal options available for breast cancer survivors, including the newly FDA approved neurokinin 1 (NK1) and neurokinin 3 (NK3) receptor antagonist, Lynkuet™.

Objectives
Upon completion of this activity, participants will be able to:
1. Assess relative contraindications to menopausal hormone therapy
2. Identify non-hormone treatment options for vasomotor symptoms
3. Describe how neurokinin receptor antagonists work to reduce vasomotor symptoms

Target Audience
Free 1 credit hour of Continuing Education for St Elizabeth Health Care providers, Pharmacists, Residents and Students

Special Services
If you require special assistance to attend this event, please call Deanna Fliehman at (859) 301-6191

Speaker
Emma Finger, PharmD
PGY2 Oncology Pharmacy Resident 
St Elizabeth Healthcare - Edgewood, Kentucky

Session date: 
01/12/2026 - 12:00pm EST to 03/12/2026 - 11:59pm EDT
Location: 
St. Elizabeth Healthcare
1 Medical Village Drive
Edgewood, KY 41017
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

  • 1.00 Participation
    UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Emma Finger, PharmD

has no relevant financial relationships to disclose at this time.